Clinical Trial Update: Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections [Phase 4]

View source ↗

Summary

Phase 4 long-term immunogenicity study of Engerix-B in 10-year-olds, evaluating the impact of booster injections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: Laval University | Conditions: Hepatitis B, Vaccination | Phase 4 | Status: COMPLETED